Zhongzhi Pharmaceutical Holdings Limited (stock code: 03737) published its monthly return for equity securities for the month ended October 31, 2025. The report shows that the total authorized share capital remained at 1,560,000,000 ordinary shares at HKD0.01 par value, amounting to HKD15,600,000. The issued share capital remained unchanged from the previous month at 863,600,000 issued shares with no treasury shares reported.

No movements in share options, warrants, or convertible securities were noted during the reporting period, and there were no indications of new agreements or arrangements to issue additional shares. The company’s submission confirms compliance with relevant listing requirements and legal obligations for this period.